These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21598253)

  • 1. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation.
    Wagner KD; Benchetrit M; Bianchini L; Michiels JF; Wagner N
    J Pathol; 2011 Aug; 224(4):575-88. PubMed ID: 21598253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
    Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
    Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
    Bishop-Bailey D; Bystrom J
    Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.
    Brunelli L; Cieslik KA; Alcorn JL; Vatta M; Baldini A
    Circ Res; 2007 Mar; 100(5):e59-71. PubMed ID: 17303761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
    Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
    Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
    J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation.
    Burdick AD; Kim DJ; Peraza MA; Gonzalez FJ; Peters JM
    Cell Signal; 2006 Jan; 18(1):9-20. PubMed ID: 16109478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine.
    Reed KR; Sansom OJ; Hayes AJ; Gescher AJ; Winton DJ; Peters JM; Clarke AR
    Oncogene; 2004 Nov; 23(55):8992-6. PubMed ID: 15480419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
    Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
    Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
    Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta.
    Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG
    Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.
    Ritzenthaler JD; Roman J; Han S
    Methods Mol Biol; 2009; 512():309-23. PubMed ID: 19347285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy.
    Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W
    ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear hormone receptor peroxisome proliferator-activated receptor beta/delta potentiates cell chemotactism, polarization, and migration.
    Tan NS; Icre G; Montagner A; Bordier-ten-Heggeler B; Wahli W; Michalik L
    Mol Cell Biol; 2007 Oct; 27(20):7161-75. PubMed ID: 17682064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
    Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
    Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblasts.
    Liang YJ; Chen CY; Juang SJ; Lai LP; Shyu KG; Wang BW; Liu SY; Leu JG
    Eur J Pharmacol; 2010 Sep; 643(1):84-92. PubMed ID: 20599914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.